Articles - Articles
- Frustrated patients deserve better healthcare strategies
In these times of super science and breakthroughs in genomics, there has never been a better opportunity to give the right treatment to the right patient at the right time, writes European Alliance for Personalised Medicine Executive Director Denis Horgan.
Not only that, but increasing patient awareness and knowledge has brought with it new demands on their behalf to be at the centre of their own treatment - part of co-decision making, and a two-way street between the patient and the front-line healthcare professionals, or HCPs.
- Democracy: Would you vote for it?
The surprise (at least to many) election of Donald J. Trump as the 45th President of the United States has thrown up some very real questions about what constitutes ‘democracy’, writes European Alliance for Personalised Medicine Executive Director Denis Horgan.
It is not so long ago that Trump, who looked to be heading for defeat, refused to say whether he would accept the result if he lost and, on several occasions, maintained that the election was being ‘rigged’.
- Twelve steps to help cure post-election ills
As the dust begins to settle on election night in the US and what many saw as a shock victory for Donald Trump, Denis Horgan, Executive Director of the European Alliance for Personalised Medicine, asks the questions: ’is America broken and can it be cured?’
- TRUMP: Total Rewrite of US Medical Policy? Will next US President prove a Trump card for a nation’s health?
With the news that Donald Trump has won a stunning victory to become the 45th President of the United States in January 2017, those working in personalised medicine and healthcare in general on both sides of the Atlantic will be watching carefully.
In 2010, current President Barack Obama launched the Affordable Care Act (dubbed Obamacare). Later he ushered in the Precision Medicine Initiative (PMI), the latter in his 2015 State of the Union address. Therefore, it was surely a little surprising that healthcare for the nation’s more-than 300 million citizens was barely touched upon in the three feisty debates leading up to this week’s elec-tion.
- Press Release: Loss of cancer pioneer will ‘leave a huge gap’ moving into the era of Personalised Medicine.
9 November, Brussels: European oncology this week lost one of its stalwarts with the death of Umberto Veronesi on 8 November, just a few weeks after of his 90th birthday.
In 1994, Italy-born Umberto founded the Milan-based European Institute of Oncology (IEO), which he directed until his death, and overall had a glittering career in the prevention and treatment of breast cancer covering more than five decades.
- Press release: Czechs and balances in the emerging world of personalised medicine
Prague, 2 November: Prague this week hosted a high-level conference on advances in healthcare and targeted treatments.
Experts in the capital of the Czech Republic joined forces to discuss the International Consortium of Personalised Medicine (known as IC PerMed) to back up European Commission moves in respect of the personalised medicine agenda.
- Press release: Bucharest hosts key conference on personalised medicine
Bucharest, October 20th: This week (October 19th) saw the Brussels-based European Alliance for Personalised Medicine (EAPM) play a key role in a cutting-edge conference in the eastern-European city of Bucharest.
The gathering followed in the wake of an earlier satellite symposium held on October 18th in the Romanian capital, also addressed by EAPM.
- Press Release: Transparent Alliance lets light shine on personalised medicine
Brussels, 12 October: The European Alliance for Personalised Medicine (EAPM) this week hosted a very different meeting inside a glass house facing the Brussels European Parliament.
‘The transparent’ gathering, held in the type of building associated with sunshine and growth, was entitled ‘Taking Stock – The role of science to realise better access to healthcare’ and attracted much interest from passers-by, as well as a full house of delegates.